Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism
- PMID: 31409916
- DOI: 10.1038/s41440-019-0312-9
Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism
Abstract
Primary aldosteronism is characterized by inappropriate overproduction of aldosterone by adrenal lesions and leads to hypertension. Excess aldosterone causes organ damage; therefore, finding a biomarker for organ damage risk is vital. The (pro)renin receptor regulates the tissue renin-angiotensin-aldosterone system. The blood soluble (pro)renin receptor concentration is a candidate biomarker that reflects the activity of the tissue renin-angiotensin-aldosterone system. This study investigated the relationships between serum soluble (pro)renin receptor concentrations and indices of organ damage in patients with primary aldosteronism. We examined plasma aldosterone and serum soluble (pro)renin receptor concentrations in patients with primary aldosteronism and evaluated the relationships between these values and organ damage indices, such as the cardio-ankle vascular index, urinary albumin excretion, estimated glomerular filtration rate, and high-sensitivity C-reactive protein levels. We enrolled 121 patients with primary aldosteronism (46 males, 54.9 ± 12.2 years of age). Serum soluble (pro)renin receptor concentrations were significantly positively correlated with the cardio-ankle vascular index, urinary albumin excretion, and high-sensitivity C-reactive protein levels and negatively associated with estimated glomerular filtration rates, independent of other factors. Plasma aldosterone concentrations showed no significant relationships with these indices. In patients with primary aldosteronism, serum soluble (pro)renin receptor concentrations, but not plasma aldosterone concentrations, showed significant associations with organ damage, suggesting that the serum soluble (pro)renin receptor level could be a high-risk biomarker of organ damage.
Keywords: Arteriosclerosis; cardio-ankle vascular index; high-sensitivity C-reactive protein; tissue renin–angiotensin–aldosterone system; urinary albumin secretion.
Similar articles
-
Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level.Hypertens Res. 2018 Jun;41(6):435-443. doi: 10.1038/s41440-018-0037-1. Epub 2018 Apr 4. Hypertens Res. 2018. PMID: 29618841 Clinical Trial.
-
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.Hypertension. 2014 Feb;63(2):297-302. doi: 10.1161/HYPERTENSIONAHA.113.02217. Epub 2013 Nov 11. Hypertension. 2014. PMID: 24218434
-
Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.Endocrine. 2017 Aug;57(2):298-307. doi: 10.1007/s12020-017-1348-8. Epub 2017 Jun 22. Endocrine. 2017. PMID: 28638984
-
[The aldosterone to Renin ratio in secondary hypertension].Herz. 2003 Dec;28(8):686-91. doi: 10.1007/s00059-003-2507-7. Herz. 2003. PMID: 14689102 Review. German.
-
Functional tests for primary aldosteronism: value of captopril suppression.Curr Hypertens Rep. 2002 Jun;4(3):245-9. doi: 10.1007/s11906-002-0014-5. Curr Hypertens Rep. 2002. PMID: 12003708 Review.
Cited by
-
Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism.Int J Endocrinol. 2020 Sep 28;2020:9640103. doi: 10.1155/2020/9640103. eCollection 2020. Int J Endocrinol. 2020. PMID: 33061968 Free PMC article.
-
Urinary soluble (pro)renin receptor excretion is associated with urine pH in humans.PLoS One. 2021 Jul 26;16(7):e0254688. doi: 10.1371/journal.pone.0254688. eCollection 2021. PLoS One. 2021. PMID: 34310595 Free PMC article.
-
(Pro)renin receptor antagonist PRO20 attenuates nephrectomy-induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/β-catenin signaling.Physiol Rep. 2021 Jun;9(11):e14881. doi: 10.14814/phy2.14881. Physiol Rep. 2021. PMID: 34057312 Free PMC article.
-
Circulating prorenin: its molecular forms and plasma concentrations.Hypertens Res. 2021 Jun;44(6):674-684. doi: 10.1038/s41440-020-00610-0. Epub 2021 Feb 10. Hypertens Res. 2021. PMID: 33564180
-
The relationship between kidney function and the soluble (pro)renin receptor in young adults: the African-PREDICT study.BMC Nephrol. 2025 Apr 3;26(1):172. doi: 10.1186/s12882-025-04038-x. BMC Nephrol. 2025. PMID: 40181300 Free PMC article.
References
-
- Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811–1820. https://doi.org/10.1016/j.jacc.2017.01.052 - DOI - PubMed
-
- Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849–1865. - DOI
-
- Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004;43:841–848. https://doi.org/10.1161/01.HYP.0000118519.66430.22 . - DOI - PubMed
-
- Matsui S, Kishimoto S, Kajikawa M, Hashimoto H, Kihara Y, Matsumoto T, et al. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism. Hypertens Res. 2018;41:932–938. https://doi.org/10.1038/s41440-018-0093-6 . - DOI - PubMed
-
- Savard S, Amar L, Plouin P-F, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331–336. https://doi.org/10.1161/HYPERTENSIONAHA.113.01060 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials